Perbak Capital Partners LLP Illumina, Inc. Transaction History
Perbak Capital Partners LLP
- $568 Billion
- Q3 2025
A detailed history of Perbak Capital Partners LLP transactions in Illumina, Inc. stock. As of the latest transaction made, Perbak Capital Partners LLP holds 32,315 shares of ILMN stock, worth $3.9 Million. This represents 0.54% of its overall portfolio holdings.
Number of Shares
32,315
Previous 18,000
79.53%
Holding current value
$3.9 Million
Previous $1.72 Billion
78.7%
% of portfolio
0.54%
Previous 0.39%
Shares
3 transactions
Others Institutions Holding ILMN
# of Institutions
906Shares Held
156MCall Options Held
4.75MPut Options Held
903K-
Capital World Investors Los Angeles, CA20MShares$2.41 Billion0.27% of portfolio
-
Black Rock Inc. New York, NY18.1MShares$2.18 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.6MShares$1.77 Billion0.02% of portfolio
-
State Street Corp Boston, MA6MShares$724 Million0.02% of portfolio
-
Sessa Capital Im, L.P. New York, NY4.69MShares$566 Million10.94% of portfolio
About ILLUMINA, INC.
- Ticker ILMN
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 157,300,000
- Market Cap $19B
- Description
- Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....